In addition, we have provided evidence that FoxO1 mediates the beneficial effect of estrogen on glucose dysregulation and heart failure under insulin resistance [69,70]; these results indicate that FoxO1 signaling contributes to the sex dimorphism observed in heart diseases and diabetes. Here, FOXO1 is linked to diabetes mellitus.